
Srika 250mg Injection
Marketer
Sristi Pharmaceuticals
Salt Composition
Amikacin (250mg)
Overview Srika 250mg Injection
Cefixime 250mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, bones, joints, lungs (such as pneumonia), brain, and bloodstream. Its prophylactic use is also common in hospitalized patients to prevent infection. This antibiotic functions by inhibiting bacterial growth. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, it requires adherence to a prescribed dosage schedule. Complete the entire course of treatment as directed, even with symptom improvement; premature discontinuation risks relapse or infection exacerbation. Common side effects include injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or lack of improvement warrant immediate medical attention. High doses may induce vertigo, nephrotoxicity, and ototoxicity; thus, strict adherence to physician instructions is crucial. Regular kidney function, hearing, and urinalysis may be conducted during treatment. This medication is contraindicated during pregnancy; disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Primary Ingredients of Srika 250mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Srika 250mg Injection
Infections caused by bacteria
Major Benefits of Srika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Srika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Srika 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Srika 250mg Injection works:
The antibiotic injection Srika 250mg inhibits bacterial proliferation by blocking the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Srika 250mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Srika 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Lactation compatibility studies show that Srika 250mg Injection poses minimal risk to nursing infants. Research in humans indicates negligible transfer of the medication into breast milk, with no observed adverse effects on the baby.
DrivingUNSAFE
Administering a 250mg Srika injection can induce drowsiness, blurred vision, and dizziness. Driving is prohibited while experiencing these effects.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Srika 250mg Injection. The prescribed dosage of Srika 250mg Injection may require modification. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Srika 250mg Injection in individuals with liver impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Srika 250mg Injection :
Omit a scheduled dose of Srika 250mg Injection? Seek medical advice immediately.
Facts to Know About Srika 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
